Valtecne S.p.A. (IT:VLT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Valtecne S.p.A. has reported a revenue of €24 million for the first nine months of 2024, marking a 0.5% increase from the previous year. The company’s medical business line has grown by 18%, now accounting for nearly 70% of total revenues, reflecting a strategic focus on the burgeoning medical sector.
For further insights into IT:VLT stock, check out TipRanks’ Stock Analysis page.